Deborah Ramsdell

CEO / COO
Board Member

Deborah Ramsdell serves as Chief Executive Officer and Chief Operating Officer for Phoenicis and has over 35 years of experience in executive management and consulting roles in early and mid-stage biopharmaceutical companies. Over the course of her career, she has been responsible for the strategic design, leadership and operational oversight of multiple drug candidates in the fields of oncology, rare metabolic diseases, dermatology, pain, infectious diseases, transplantation, cardiology, renal diseases, and endocrinology.

From 2012 – 2019, she held the position of CEO of Valerion Therapeutics, a clinical stage company developing a platform to treat rare glycogen storage disorders. She was also CEO of Wings Therapeutics from 2019 – 2020, a clinical stage company developing antisense oligonucleotides to treat a rare genetic dermatological disorder, which is one of the companies that was incorporated into Phoenicis Therapeutics.